We are live on ! Find out more
FCBT

First Citizens Bank & Trust Portfolio holdings

AUM $6.69B
1-Year Est. Return 24.48%
This Fund
S&P 500
This Quarter Est. Return
+4.44%
1 Year Est. Return
+24.48%
3 Year Est. Return
+60.29%
5 Year Est. Return
+62.67%
10 Year Est. Return
+281.03%
AUM
$1.17B
AUM Growth
+$67.8M
Cap. Flow
+$24.3M
Cap. Flow %
2.07%
Top 10 Hldgs %
17.61%
Holding
381
New
63
Increased
147
Reduced
123
Closed
44

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$20.7M
2
INTC icon
Intel
INTC
+$7.03M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.96M
4
PNC icon
PNC Financial Services
PNC
+$6.62M
5
MS icon
Morgan Stanley
MS
+$5.84M

Sector Composition

Rank Sector Weight
1 Financials 18.03%
2 Technology 13.62%
3 Healthcare 12.78%
4 Industrials 9.69%
5 Energy 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TXN icon
251
Texas Instruments
TXN
$255B
$361K 0.03%
7,550
-3,235
-30% -$151K
HBI
252
DELISTED
Hanesbrands
HBI
$348K 0.03%
14,160
-268
-2% -$5.53K
BT
253
DELISTED
BT Group plc (ADR)
BT
$344K 0.03%
10,472
-58
-0.6% -$1.86K
BMY icon
254
Bristol-Myers Squibb
BMY
$132B
$338K 0.03%
+6,958
New +$343K
BRK.B icon
255
Berkshire Hathaway Class B
BRK.B
$1.1T
$337K 0.03%
2,667
-268
-9% -$33.9K
ESRX
256
DELISTED
Express Scripts Holding Company
ESRX
$336K 0.03%
+4,852
New +$341K
ROP icon
257
Roper Technologies
ROP
$38.5B
$334K 0.03%
+2,290
New +$320K
BIIB icon
258
Biogen
BIIB
$30.7B
$324K 0.03%
1,029
-71
-6% -$21.4K
ACN icon
259
Accenture
ACN
$99.9B
$320K 0.03%
3,958
-466
-11% -$37.4K
NSC icon
260
Norfolk Southern
NSC
$75B
$315K 0.03%
3,059
-887
-22% -$87K
CXT icon
261
Crane NXT
CXT
$2.97B
$313K 0.03%
12,132
-5,007
-29% -$126K
BHI
262
DELISTED
Baker Hughes
BHI
$313K 0.03%
+4,208
New +$293K
ITW icon
263
Illinois Tool Works
ITW
$81.6B
$309K 0.03%
3,526
-801
-19% -$68.8K
PKG icon
264
Packaging Corp of America
PKG
$22.2B
$306K 0.03%
4,281
+72
+2% +$4.95K
KRFT
265
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$303K 0.03%
5,056
-424
-8% -$24.5K
TRN icon
266
Trinity Industries
TRN
$2.73B
$301K 0.03%
9,567
-153
-2% -$4.34K
C icon
267
Citigroup
C
$222B
$297K 0.03%
6,307
-78,484
-93% -$3.73M
WMB icon
268
Williams Companies
WMB
$86.7B
$297K 0.03%
+5,100
New +$236K
IP icon
269
International Paper
IP
$22.8B
$293K 0.03%
6,217
+381
+7% +$16.7K
TIF
270
DELISTED
Tiffany & Co.
TIF
$293K 0.03%
2,921
-943
-24% -$87.5K
FL
271
DELISTED
Foot Locker
FL
$289K 0.02%
+5,693
New +$272K
RTN
272
DELISTED
Raytheon Company
RTN
$289K 0.02%
3,130
+146
+5% +$14.2K
SHLM
273
DELISTED
Schulman (A.) Inc
SHLM
$278K 0.02%
+7,190
New +$259K
AAP icon
274
Advance Auto Parts
AAP
$3.39B
$277K 0.02%
2,055
-252
-11% -$31.2K
EHC icon
275
Encompass Health
EHC
$11B
$276K 0.02%
9,656
-374
-4% -$10.4K

Similar funds

First Citizens Bank & Trust's Q2 2014 Portfolio in Review

As of Q2 2014, First Citizens Bank & Trust held 381 positions worth $1.17B, up 6.1% from $1.11B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

First Citizens Bank & Trust's Q2 2014 filing shows 63 new, 147 increased, 123 reduced and 44 closed positions. Its largest new stake was Teva Pharmaceuticals: 136,228 shares worth $7.14M. The largest sale was Cencora, an estimated $11.5M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • First Citizens Bank & Trust's largest Q2 2014 buy was Teva Pharmaceuticals: 136,228 shares worth $7.14M.
  • First Citizens Bank & Trust added most to AT&T in Q2 2014, an estimated $20.7M increase.
  • First Citizens Bank & Trust's biggest Q2 2014 reduction was Fifth Third Bancorp, cutting an estimated $6.51M.
  • First Citizens Bank & Trust fully exited Cencora in Q2 2014, selling an estimated $11.5M.
  • First Citizens Bank & Trust's ten largest holdings make up 18% of its $1.17B portfolio in Q2 2014.
  • First Citizens Bank & Trust opened 63 new positions and closed 44 in Q2 2014.
  • First Citizens Bank & Trust's portfolio value rose 6.1% quarter-over-quarter to $1.17B.

Based on First Citizens Bank & Trust's 13F filing for Q2 2014, filed 5 Aug 2014.